USE OF AN ANTICHANGERIGEN PHARMACO NOT ENCAPSULATED FOR THE PREPARATION OF A FORMULATION TO TREAT NEOPLASIAS BY INHLATION.

摘要

Use of a safe and effective dose of an anticancer drug not encapsulated in a pharmaceutically acceptable carrier or carrier for the preparation of a formulation to treat a neoplasm in a patient by inhalation, in which the anticancer drug is selected from the group consisting of epirubicin , daunorubicin, methoxymorpholinodoxorubicin, cyanomorpholinyldoxorubicin, doxorubicin and idarubicin, and in which the anticancer drug is inhaled in the absence of perfluorocarbon.